Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors
An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. More »
